Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies

Caitlin Costello, MD, discusses the role and safety of bispecific antibodies approved for the treatment of relapsed/refractory multiple myeloma as well as emerging data and clinical trials with this treatment approach.